Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system by Pereira, Jorge A. et al.
JCB: ARTICLE
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 185 No. 1  147–161
www.jcb.org/cgi/doi/10.1083/jcb.200809008 JCB 147
Correspondence to João B. Relvas: joao.relvas@cell.biol.ethz.ch
Abbreviations used in this paper: BL, basal lamina; CI, crush injury; Dhh, desert 
hedgehog; DRG, dorsal root ganglia; GSK3, glycogen synthase kinase 3; 
ILK, integrin-linked kinase; IPP, ILK–PINCH–parvin; MBP, myelin basic protein; 
MP, microtubule protection; PINCH, particularly interesting new Cys-His–rich 
protein; PLP, proteolipid protein; PNS, peripheral nervous system; ROCK, Rho 
kinase; SC, Schwann cell; SN, sciatic nerve.
Introduction
Myelination of axons promotes neuronal survival and greatly 
increases the conduction velocity of nerve impulses. The con­
trol  of  Schwann  cell  (SC)  differentiation  and  myelination   
derives at least in part from instructive cues originating within the 
extracellular environment. These signals include growth factors 
and proteins of the ECM as essential components (Colognato   
et al., 2005). Integrins, a major group of cell adhesion recep­
tors for the proteins of the ECM, are composed of two non­
covalently associated transmembrane glycoprotein subunits,   
 and , both of which participate in the binding of ECM proteins.   
Ligand binding recruits cytoskeleton and signaling molecules to 
cell matrix contact sites where they link the actin cytoskeleton 
to the ECM and mediate signal transduction between the extra­
cellular and the intracellular compartments (Hynes, 1992). In SCs, 
the genetic deletion of the 1­integrin gene (Feltri et al., 2002) 
causes defects in SC–axon contact and impairs the capacity   
of SCs to extend cytoplasmic processes into embryonic axon 
bundles to establish 1:1 relationships with individual axons, a 
process referred to as radial sorting. SC­specific deletion of 
FAK (Grove et al., 2007) or Rac1 (Benninger et al., 2007; Nodari 
et al., 2007), proteins involved in 1­integrin–mediated signal­
ing, also results in deficient radial sorting. However, distinct cel­
lular defects can underlie a common radial sorting phenotype. In 
FAK mutant nerves, impairment in radial sorting is likely to   
be caused by reduced SC proliferation and not by defects in 
SC–axon contact (Grove et al., 2007), similar to defects observed 
in SC­specific Cdc42 (cell division cycle 42)­deficient nerves 
(Benninger et al., 2007).
Integrin­linked kinase (ILK), a 52­kD protein identified 
and cloned based on its interaction with the 1­integrin cyto­
plasmic domain (Hannigan et al., 1996), is thought to be an   
essential regulator of integrin and growth factor–mediated   
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signaling, functioning both as an adaptor protein and as a   
putative serine/threonine kinase. It consists of three domains: 
four N­terminal ankyrin repeats, a putative pleckstrin homol­
ogy domain, and a C­terminal kinase domain. As an adaptor 
protein, ILK binds to particularly interesting new Cys­His–
rich protein (PINCH) via its N­terminal domain and to parvins 
via its kinase domain to form a ternary complex that subse­
quently locates to cell–ECM adhesions. There, ILK binds the 
cytoplasmic domains of activated 1­ and 3­integrin sub­
units, and the ILK–PINCH–parvin (IPP) complex can func­
tion  as  a  signaling  platform  downstream  of  integrins  by 
interfacing with the actin cytoskeleton and several different 
signaling pathways (Legate et al., 2006). The IPP complex can 
bind to filamentous actin via parvin and paxillin, which also 
binds directly to the ILK C­terminal kinase domain. Paxillin 
also binds to guanine nucleotide exchange factors, providing   
a connection between ILK and the GTPases of the Rho sub­
family (Rosenberger et al., 2003) of which at least Cdc42 and 
Rac1 regulate SC development (Benninger et al., 2007; Nodari 
et al., 2007). Via PINCH, the complex can bind to the receptor 
tyrosine  kinase–binding  adaptor  protein  Nck­2  (Tu  et  al., 
1998), establishing a potential direct link between ILK and 
growth factor signaling. Via its kinase domain, ILK is also 
thought to phosphorylate glycogen synthase kinase 3 (GSK3) 
and AKT/PKB, which are involved in signaling pathways reg­
ulating proliferation, survival, and differentiation of different 
cell types (Legate et al., 2006), including SCs (Campana et al., 
1999; Maurel and Salzer, 2000; Ogata et al., 2004). However, 
the direct phosphorylation of AKT/PKB by ILK is contro­
versial (Legate et al., 2006).
In this study, we used conditional transgenic approaches 
in the mouse to investigate the roles of ILK in SC development 
in combination with cell culture experiments. We show that ILK 
is essential for radial sorting and axon remyelination and that 
the regulation of these two events is likely to require the activa­
tion of different signaling pathways.
Results
Conditional ablation of ILK in SCs
We conditionally ablated ILK by expressing Cre recombinase 
under the control of the desert hedgehog (Dhh) gene regulatory 
sequences (Fig. 1 A). Cre is active in SC precursors from embry­
onic day (E) 12 (Joseph et al., 2004). Recombination of the con­
ditional ILK allele (Fig. 1 A) significantly reduced ILK in lysates 
obtained from sciatic nerves (SNs) of postnatal (P) day 1 mutant 
mice (Fig. 1 B). Loss of ILK also led to a strong reduction in the 
protein levels of the IPP complex members PINCH1, PINCH2, 
­parvin, and ­parvin (Fig. 1 F). Cultured P1 mutant SCs were 
ILK negative in contrast to their control counterparts (Fig. 1 C). 
ILK immunoreactivity was strongly reduced in E17.5 mutant 
nerves compared with controls (Fig. 1 D). At P14, sciatic mutant 
Figure 1.  Recombination of the conditional ILK allele in SCs of mutant 
mice. (A) Regulatory sequences of the Dhh promoter drive the expression of 
the Cre recombinase (Cre Rec.) in SCs. Partial map of the ILK allele depicts 
the location of the loxP sequences. Upon Cre-mediated recombination, the   
genomic region located between the two loxP sites, which includes exon 2   
and part of exon 1, is excised, thereby inactivating the conditional ILK 
allele. (B) Western blot analysis of protein lysates obtained from P1 SNs 
reveals a significant reduction in ILK levels compared with those of controls 
(Ctrl; n = 3, P < 0.0001). The low residual ILK protein levels detected in 
mutant (Mut) lysates are likely a result of the presence of endoneurial fibro-
blasts and some unrecombined SCs. Error bar indicates ± SEM. ***, P < 
0.001. (C) Immunostaining of acutely plated SCs obtained from P1 control 
and mutant mice using antibodies for ILK and S100 (SC marker) reveals   
loss of ILK in mutant SCs. (D) Immunohistochemistry in E17.5 SN cryo-
sections demonstrates loss of ILK in the mutant SCs in vivo. (E) Control and 
mutant SNs from P14 littermates. Note that mutant mice have thinner and 
 
more transparent SNs. (F) Upon conditional ablation of ILK, other protein 
members of the IPP complex (PINCH1 and 2 and parvin- and -) are 
reduced in P5 mutant SN lysates compared with controls. Bars, 50 µm.149 ILK IN PNS MYELINATION • Pereira et al.
Axon sorting and myelination deficits in ILK 
mutant nerves
During  postnatal  development,  SCs  progressively  segregate  and 
myelinate individual large caliber axons from axon bundles (Fig. 2, 
c, e, g, i, and k). At E17.5, SCs were present between bundles of 
nerves were thinner and more transparent than controls (Fig. 1 E). 
ILK mutants displayed progressive hind limb paresis, which de­
veloped into paralysis at around P50. As a result of the severity 
of the phenotype and legal requirements, most experiments were 
performed at P24 or earlier.
Figure 2.  Axonal sorting and myelination are impaired in 
ILK mutant SNs. (a–l) 0.5-µm SN cross sections stained with   
Toluidine blue. Early in development (a–f), SCs are in close 
association  with  bundles  of  naked  axons  (c–f;  asterisks).   
(c and d) Progressively individual axons are sorted from these   
bundles in a process referred to as radial sorting (arrowheads). 
(g, i, and k) In control nerves, individual large caliber axons are   
wrapped and myelinated. (h, j, and l) In the mutant nerves, 
radial sorting and myelination are impaired, and axon bun-
dles persist into adulthood. Bars, 10 µm.JCB • VOLUME 185 • NUMBER 1 • 2009   150
tightly apposed axons in the SNs of control and mutant mice 
(Fig. 2, a and b). In P14 control mice (Fig. 2 g), large caliber 
axons were engaged in a 1:1 relationship with SCs. By P24, myelin­
ation was virtually complete (Fig. 2 i). In contrast, in the mutant 
nerves, axon sorting and myelination was impaired, and bundles 
of axons containing large caliber axons persisted at P50, the latest 
stage analyzed (Fig. 2 l). Few axons were myelinated in mutant 
nerves at all stages analyzed (Fig. 2, d, f, h, j, and l). Myelinating 
SCs in mutant nerves were not recombined, as they expressed 
both ILK and myelin basic protein (MBP; Fig. S2).
We conclude that the differentiation of mutant SCs is   
severely impaired. This conclusion is also supported by the find­
ings that mutant nerves showed increased Oct6 immunoreactivity 
and reduced mRNA levels for several myelin genes compared 
with controls (Fig. S3, A and B).
ILK is required for proper extension and 
stabilization of SC processes
EM analysis at P5 showed that control and mutant nerves con­
tained SCs at different stages of differentiation, including imma­
ture SCs associated with axon bundles, promyelinating SCs in a 
1:1 relationship with large caliber axons, and SCs starting to my­
elinate. In control nerves, immature SCs extended long processes 
that fully enveloped axon bundles (Fig. 3 A, a and c). This was in 
contrast to mutant nerves in which immature SC processes often 
failed to completely envelop axon bundles (Fig. 3 A, b and d).
At the promyelinating stage, SC–axon profiles in control 
nerves were encircled by a tightly apposed basal lamina (BL; 
Fig. 3 A, e). In mutant nerves, these profiles contained aberrant 
cytoplasmic protrusions (Fig. 3 A, f). The surface of these protru­
sions was covered by BL. Often, empty loops of redundant BL, 
continuous with the apposed BL, were also present (Fig. 3 A, f). 
These loops are likely to be detached BL left behind by retract­
ing protrusions, suggesting that SC processes repeatedly engaged 
and retracted from axons.
At P24, radial sorting in control nerves was completed 
(Fig. 3 B, a). Small caliber axons were engaged by nonmyelin­
ating SCs (Fig. 3 B, c), and myelinating SCs were surrounded 
by an apposed BL (Fig. 3 B, e and g). Mutant nerves were   
severely hypomyelinated. Axon bundles in mutant nerves were still 
Figure  3.  Process  extension  and  BL  organization  are  impaired  in  ILK  
mutant SCs. (A and B) EM micrographs of SN ultra-thin sections at P5 (A) and 
P24 (B). (A) At P5, immature SCs extend processes (white arrowheads) that 
fully envelop bundles of axons (a and c), which is a typical feature at this 
stage of maturation. In mutant nerves (b and d), SC processes often fail to   
completely enwrap axon bundles (black arrowheads). In controls, pro-
myelinating SCs are surrounded by a tightly associated BL (e, white arrows). 
In contrast, mutant promyelinating SCs display cytoplasmic protrusions at 
the cell surface (f, gray arrows), frequently associated with a disorganized 
BL that forms loops detached from the plasma membrane (f, black arrows). 
Myelinating SCs could be found in controls, and some were also present 
in mutant nerves (asterisks). Bars: (b) 5 µm; (a and d) 2 µm; (c, e, f) 1 µm. 
(B) At P24, there are virtually no remaining axon bundles on the control 
nerves. Large caliber axons have been engaged and are myelinated (a, c, 
and e), whereas small caliber axons, which will not be myelinated during 
development, are engaged by nonmyelinating SCs (c, white arrowhead). 
In mutant nerves, axonal sorting is severely impaired, and many bundles   
persist. Mutant SCs associated with axon bundles fail to completely sur-
round them (black arrowheads), resembling the phenotype observed 
at P5 (b and d). Unsorted axons are surrounded by loops of BL (black   
arrowheads). Control myelinating SCs reveal a tightly associated single BL 
(g, white arrows) in contrast to ILK-null cells in which multiple cytoplasmic 
protrusions (gray arrows) are visible (f), which are frequently associated 
with empty loops of BL (h; black arrows). Boxes indicate regions that are 
shown at a higher magnification in the panels below. Bars: (b) 5 µm; (a, c, 
d, and f) 2 µm; (e and h) 1 µm; (g) 0.2 µm.
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In addition, using whole genome genechip arrays, we found that 
the mRNA levels of the atypical Rho GTPase RhoE, an impor­
tant inhibitor of Rho/ROCK activity (Riento et al., 2003), were 
markedly reduced in ILK mutant nerves as compared with con­
trols (unpublished data). Therefore, we analyzed the levels of 
RhoE in protein lysates obtained from ILK mutant and control 
nerves by Western blotting. Our results show that there was a 
dramatic reduction of RhoE expression levels in mutant ly­
sates as compared with controls (Fig. S4 B, a). This reduction 
was confirmed by immunohistochemistry (Fig. S4 B, b) on 
cross sections obtained from control and mutant nerves and by 
immunocytochemistry in control and ILK mutant SCs in cul­
ture (Fig. S4 B, c).
Radial sorting is largely reestablished in 
the nerves of postnatal mutant ILK mice 
after injection of the ROCK inhibitor fasudil
To investigate whether inhibition of ROCK could reestablish 
radial sorting in mutant nerves, we injected mutant mice with 
either PBS or fasudil. Fasudil has been used to inhibit ROCK in 
vivo in various experimental settings (Mueller et al., 2005) and 
also in humans (Shimokawa et al., 2002). Injection of fasudil in 
control mice did not affect SC differentiation or myelination 
(Fig. 5 A, b). However, we found that fasudil treatment was able 
to reestablish radial sorting in the nerves of mutant mice (Fig. 5,   
A [d] and B [b and d]). Nerves of fasudil­injected mutant mice 
contained axon bundles of significantly smaller size than those 
of the PBS­injected mutant mice (Fig. 5 B, e). There was also a 
striking increase in the numbers of putative freshly sorted 1:1 
SC–axon profiles in the nerves of fasudil­injected mutant mice 
(Fig. 5 B, b, d, and f). The numbers of myelinated fibers in PBS­ 
or fasudil­injected mutant mice SNs, however, were not signifi­
cantly different (Fig. 5 g). We conclude that inhibition of ROCK 
improves radial sorting but not myelination per se, suggesting 
that ILK function is also required for axonal myelination.
Reduced levels of phospho–Ser-473 of 
AKT/PKB in mutant nerves
Regulation of SC myelination, survival, and proliferation by 
SC–ECM  interactions,  exposure  to  neuregulin­1,  PDGF,  or 
IGF­1, or by axonal contact is thought to require AKT/PKB ac­
tivation (Campana et al., 1999; Maurel and Salzer, 2000; Ogata 
et al., 2004; Nave and Salzer, 2006). AKT/PKB activation re­
quires phosphorylation on Thr­308 and Ser­473. Although Thr­308 
is phosphorylated by 3­phosphoinositide–dependent protein   
kinase­1, the identity of the Ser­473 kinase is unclear (Legate   
et al., 2006). One candidate is ILK, which has been shown to 
regulate phosphorylation of AKT/PKB on Ser­473 in different 
cell types (Persad et al., 2001; Troussard et al., 2003). Thus, we 
analyzed the levels of AKT/PKB phosphorylation of Ser­473 
and Thr­308 in protein lysates obtained from ILK mutant and 
control nerves by Western blotting. Although at all stages analyzed 
the levels of AKT/PKB phosphorylation on Ser­473 in mutant 
lysates were significantly lower than those of their control coun­
terparts, the levels of AKT/PKB phosphorylation on Thr­308 in 
mutant lysates were significantly higher than in controls (Fig. 6 A). 
Total levels of AKT/PKB were slightly reduced (Fig. 6 A).   
not completely enveloped by immature SC processes (Fig. 3 B, 
b and d). As in P5 mutant nerves, layers of loose BL surrounded 
naked axon bundles and promyelinating SC–axon profiles (Fig. 3 B, 
d, f, and h).
We conclude that loss of ILK in SCs appears to lead to de­
fects in process extension and stabilization. Such defects are 
likely to be the reason why radial sorting was impaired in mu­
tant nerves.
ILK regulates SC process extension in a 
Rho kinase (ROCK)–dependent manner
As several studies link ILK to the regulation of Rho GTPase 
activity (Legate et al., 2006), we performed Rho GTPase activ­
ity assays in SN lysates (Benninger et al., 2007) obtained from 
P5 mutant and control mice. The expression levels of Cdc42 
and Rac1 did not differ significantly between mutant and con­
trol nerves, but the activities of Cdc42 and Rac1 were signifi­
cantly increased in mutant nerve lysates as compared with 
controls (Fig. 4 A). Rho activity was also significantly in­
creased, but its expression levels were significantly decreased. 
ROCK (Riento and Ridley, 2003) is an effector of Rho, which 
inhibits  neurite  outgrowth  in  neurons  (Luo,  2002)  and  out­
growth of processes in SCs (Melendez­Vasquez et al., 2004). 
Thus,  we  used  ROCK  inhibitors  to  investigate  whether  the 
shorter SC processes observed in mutant nerves were a conse­
quence of increased ROCK activity.
Mutant SC cultures contained significantly more cells with 
shorter processes than those of control cultures (Fig. 4 B, a–c). 
Exposure to the selective ROCK inhibitors Y27632 (10 µM) or 
HA­1077 (fasudil; 40 µM; Melendez­Vasquez et al., 2004) in­
creased the number of SCs with longer processes in both control 
and mutant cultures. However, control and mutant SCs no longer 
exhibited significant differences in SC process length (Fig. 4 B, 
d–i). The  different  concentrations  used  for  fasudil  and Y27632 
might explain why SCs in cultures exposed to fasudil produced 
longer processes compared with those exposed to Y27632   
(Fig. 4 B, f and i). We conclude that the shorter process length of 
mutant SCs is likely a result of increased Rho/ROCK activation.   
In addition, we used time­lapse video microscopy to evaluate   
the dynamics of control and mutant SC process extension and 
retraction. We recorded the behavior of SCs in control and mutant 
cultures in the presence or absence of fasudil over a period of   
12 h (Videos 1–4 and Fig. S3 F). Our data show that the mean 
number of complete process retraction events per SC in mutant 
cultures is more than eight times higher than seen in controls or 
mutant cultures treated with fasudil (Fig. S3 F). There was no 
significant  difference  in  the  number  of  extension/retraction 
events among SCs of control, control treated with fasudil, or mu­
tant treated with fasudil (Fig. S3 F). Overall, these results sup­
port the hypothesis that the loss of ILK regulates SC process 
extension and stabilization mainly via Rho/ROCK signaling.
In  some  cell  types,  ILK  can  negatively  regulate  Rho/
ROCK activity by integrin­dependent FAK activation (Tahiliani 
et al., 1997; Wennerberg et al., 2000; Parsons, 2003) and pax­
illin phosphorylation (Chen et al., 2005). Accordingly, we show 
that in ILK mutant nerve lysates, the activation of FAK and   
paxillin were reduced as compared with controls (Fig. S4 A).   JCB • VOLUME 185 • NUMBER 1 • 2009   152
Figure 4.  ILK regulates SC process extension in a Rho/ROCK-dependent manner. (A) Pull-down assays for active GTP-bound Rho GTPases using SN lysates 
obtained from P5 control and mutant mice. The activity of Cdc42 (n = 4, P = 0.0096) and Rac1 (n = 4, P = 0.0012) is significantly increased in mutant 
lysates, whereas their total expression levels are not. The amounts of activated Rac1 are more abundant in mutant than control SNs (n = 4, P = 0.0017), 
and although not statistically significant, the amounts of activated Cdc42 are also increased (n = 4, P = 0.0511). The aggregate activation of RhoA, B, and C 
(n = 4, P = 0.0015), termed Rho, is significantly increased in mutant lysates, whereas their total expression is significantly decreased (n = 4, P = 0.0017). 
Altogether, there is still more activated Rho protein in mutant than control SNs (n = 4, P = 0.0050). The Rho antibody used for Western blotting, after the 
coprecipitation with the recombinant rhotekin fragment, is not specific for individual Rho isoforms. (B, a and b, d and e, and g and h) Immunocytochemistry 
to reveal the cytoskeleton of control and mutant mouse SCs plated on laminin-2 for 24 h. Categorization of control and mutant SCs according to process 
length. (a–c) There is a higher frequency of SCs with shorter processes in mutant SC cultures as compared with control cultures (n = 3; P26–50 = 0.026; P51–75 = 
0.016; P76–100 = 0.0071; P101–150 = 0.036; P151–200 = 0.020; P201–250 = 0.0048). Treatment of the SCs with the ROCK inhibitor Y27632 (d–f) or fasudil 
(g–i) restores process extension in mutant cells. Error bars indicate ± SEM. *, P < 0.05; **, P < 0.01. Bars, 20 µm.153 ILK IN PNS MYELINATION • Pereira et al.
Interestingly, the phosphorylation levels of GSK3, an­
other putative ILK substrate, remained unchanged in mutant 
nerves compared with controls (Fig. 6 B), suggesting that the 
mechanisms of AKT/PKB and GSK3 activation are different 
(Legate et al., 2006).
Collectively, these results are consistent with the view that ILK 
regulates AKT/PKB activation during peripheral nervous sys­
tem (PNS) myelination and that ILK function is required for 
phosphorylation of AKT/PKB on Ser­473 (Persad et al., 2001; 
Troussard et al., 2003).
Figure 5.  Inhibition of ROCK signaling facilitates   
axonal sorting in ILK mutant mice. ILK conditional control 
and mutant mice were injected i.p. with either PBS or 
40 mg/kg/d fasudil over six consecutive days from 
P8 to P13. SNs were collected at P14. (A, a–d) Tolu-
idine blue–stained 0.5-µm semithin sections of control 
and mutant animals injected with either fasudil or with 
PBS only. (a and b) There were no visible differences 
in  myelination  between  fasudil-  and  PBS-injected 
control nerves. Bars, 10 µm. (B, a–d) Electron micro-
graphs of mutant animals injected with either fasudil 
or  with  PBS  only.  PBS-injected  mutant  mice  display 
large unsorted axonal bundles (a and c) as seen be-
fore, whereas bundles in fasudil-injected mutant mice 
are smaller (b and d; n = 3; P0–5 = 0.012; P6–10 = 
0.0064; P51–100 = 0.011; P101–250 = 0.027). (e) Quan-
tification of the unsorted bundle area reveals a higher 
frequency of small bundles in the fasudil-injected mice 
(6–25 µm
2) and a higher frequency of large bundles 
in PBS-injected mice (51 to >250 µm
2). Crosses indi-
cate that no bundles within the size category were 
found in any of the animals analyzed. In the axonal 
bundle depicted in d, asterisks mark axons that have 
presumably been recently sorted and are larger than 
those remaining in the bundle. (f and g) There is a 
significant increase in the number of 1:1 relations in 
fasudil- versus PBS-injected mutant animals (f; n = 3,   
P = 0.0052); however, the total number of myelinated 
axons in the nerves analyzed does not differ between 
PBS- and fasudil-injected mice (g). Error bars indicate 
± SEM. *, P < 0.05; **, P < 0.01. Boxes in a and b 
indicate regions that are shown at a higher magnifica-
tion in c and d, respectively. Bars: (a and b) 5 µm;   
(c) 2 µm; (d) 1 µm.JCB • VOLUME 185 • NUMBER 1 • 2009   154
CreERT2 translocates to the nucleus after injection of tamoxi­
fen (Leone et al., 2003; Atanasoski et al., 2006). This allowed us 
to adjust the timing of ILK gene inactivation to our experimen­
tal requirements.
We  injected  2­mo­old  control  and  mutant  mice  with 
tamoxifen, and 2 mo later, crushed their SNs unilaterally. 7 d 
later, both noncrushed and crushed nerves were removed and 
lysed. Western blot analysis of these lysates confirmed that the 
levels of ILK in noncrushed and crushed mutant nerves were 
reduced compared with controls (Fig. 7 B). The loss of ILK in 
noninjured and injured nerves also led to a sizable reduction in 
The formation of myelin sheaths after SN 
crush injury (CI) is impaired in ILK mutants
SN CI induces Wallerian degeneration in the nerve stump distal 
to the injury site followed by rapid axonal regeneration and re­
myelination (Chen et al., 2007). Radial sorting is no longer   
required before remyelination in contrast to developmental   
myelination. For these experiments, we used mutant and control 
mice expressing CreERT2 (Indra et al., 1999; Li et al., 2000; 
Fig. 7 A) under the transcriptional control of the mouse proteo­
lipid  protein  (PLP)  gene  regulatory  elements  (Leone  et  al., 
2003). This transgene is transcriptionally active in SCs, and 
Figure 6.  ILK regulates PKB/AKT phosphorylation. (A) AKT 
phosphorylation on Ser-473 is reduced in P1, P5, and P14 
mutant nerves (n = 4, PP1 = 0.00088; n = 4, PP5 = 0.00090; 
n = 5, PP14 < 0.0001) unlike phosphorylation on Thr-308, 
which is higher in the mutants (n = 6; PP1 = 0.0018; PP5 = 
0.0062; PP14 = 0.010). AKT total levels are slightly reduced 
in the mutants (n = 10, PP1 = 0.027; n = 10, PP5 = 0.010;   
n = 11, PP14 = 0.019). (B) GSK3 phosphorylation levels are   
not reduced in the absence of ILK either at P1 or P5. Error bars 
indicate ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.155 ILK IN PNS MYELINATION • Pereira et al.
the expression levels of PINCH1 and in AKT/PKB phosphory­
lation (Ser­473; Fig. 7 B). The loss of ILK did not affect the 
maintenance  of  the  myelin  membrane  in  noninjured  nerves 
from tamoxifen­induced mutant mice (Fig. 7 C, f) nor did injec­
tion of tamoxifen impact on the myelination status of control 
nerves (Fig. 7 C, e). Distally from the crush site in injured 
nerves (Fig. 7 C, a–d), remyelination of mutant nerves was pro­
foundly impaired (Fig. 7 C, b and d) compared with controls. 
Although these nerves contained sufficient numbers of SCs to 
engage virtually all axons (Fig. 7 C, d), a large proportion of 
SC–axon units were devoid of myelin sheaths (Fig. 7 C, g). 
Despite the deficits in remyelination, the number of axons per 
area in mutant nerves 4 mo after CI was not significantly different 
from that in control nerves (Fig. 7 C, h). Corroborating the mor­
phological data, Oct6 immunoreactivity was markedly increased 
in mutant nerves at 2 mo after CI (Fig. 7 D).
These data suggest that ILK plays a direct role in SC re­
myelination but is not required for myelin maintenance. In the 
absence of ILK, remyelination of mutant crushed nerves was 
profoundly impaired. It is likely that this impairment is the re­
sult of a reduction in the levels of activity of signaling mole­
cules, including AKT/PKB.
Discussion
We demonstrate that ILK plays an essential role in the regula­
tion of radial sorting of axon bundles and in the remyelination 
of axons. During radial sorting of axon bundles, ILK negatively 
regulates Rho/ROCK signaling to control SC process extension. 
After SN CI, ILK facilitates axon remyelination presumably 
through the regulation of downstream signaling molecules such 
as AKT/PKB (Fig. 8).
ILK regulates radial sorting
Radial sorting is a key event in the development of the PNS. 
ECM–integrin interactions are important regulators of this pro­
cess, and SC­specific ablation of laminins (Feltri and Wrabetz, 
2005) or 1­integrin (Feltri et al., 2002) leads to defects in radial 
sorting. 1­integrin activates the small GTPase Rac1 to regu­
late radial sorting (Benninger et al., 2007; Nodari et al., 2007), 
Figure 7.  ILK regulates PNS remyelination. (A) Cre-mediated recombi-
nation was induced in 2-mo-old control and mutant mice by five daily 
consecutive tamoxifen injections. A period of 2 mo was allowed for re-
combination and protein depletion before assays were performed. Cre 
Rec., Cre recombinase; 2MPC, 2 mo post-CI; 4MPC, 4 mo post-CI.   
(B) Western blots performed on protein lysates obtained from contralateral 
and crushed nerves show a reduction in ILK levels in mutant (mut) nerves 
compared with those of controls (cont). PINCH1 and AKT phosphorylation 
levels are reduced in mutant nerves compared with controls. (C) Semithin 
sections of SNs collected 2 and 4 mo after CI. In contrast to controls (a, c, 
and g), mutant nerves show a significant reduction in the number of remy-
elinated axons at 2 and 4 mo after CI (b, d, and g; n = 3, P < 0.0001). 
In d, the low magnification EM insert shows that in mutant SNs, virtually 
all axons are engaged by SCs (arrowheads) but only very few went on to 
myelinate (arrow). (e) Tamoxifen (TAM) treatment does not affect myelina-
tion. (f) Noninjured mutant nerves collected 6 mo after tamoxifen induction 
show no structural abnormalities, implying that ILK is not necessary for 
the maintenance of the myelin membrane. (h) There was no difference in   
the axonal number in mutant crushed nerves when compared with con-
trol crushed nerves. (D) Oct6 immunohistochemistry on 2-mo post-CI cryo-
sections. Oct6 is virtually absent in control nerves, whereas levels are still 
high in mutant nerves. Error bars indicate ± SEM. ***, P < 0.001. Bars: 
(C) 10 µm; (D) 50 µm.
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threshold number of SCs is required to initiate this process.   
Ablation of genes involved in SC proliferation such as Cdc42 
(Benninger et al., 2007) or FAK (Grove et al., 2007) resulted in 
radial sorting impairment. In ILK mutant nerves, the numbers   
of SCs were normal and neither proliferation nor survival was 
affected. (Fig. S3, C–E). Therefore, and similarly to what has 
been postulated for 1-integrin (Feltri et al., 2002) and Rac1 
(Benninger et al., 2007; Nodari et al., 2007) mutant nerves, we 
consider  it  likely  that  the  radial  sorting  impairment  in  ILK   
mutant nerves is a direct consequence of deficits in SC process 
extension. Our data supporting this view include (a) the inabil­
ity of immature ILK­deficient SCs to completely envelop axon 
but  the  signaling  pathways  controlling  this  process  remain 
largely unknown. We demonstrate that SC­specific ablation   
of ILK, an important regulator of integrin and growth factor–
mediated signaling (Legate et al., 2006), profoundly impairs   
radial sorting in SNs. Dorsal and ventral nerve roots were   
also affected and contained several nonsorted axon bundles as   
well as 1:1 nonmyelinated profiles exhibiting empty loops of 
redundant BL (Fig. S1). Such BL protrusions are similar to those 
found in the SNs of 1­integrin and Rac1 SC­specific mutants 
(Feltri et al., 2002; Benninger et al., 2007; Nodari et al., 2007). 
SC proliferation is associated with radial sorting (Webster, 1971; 
Martin and Webster, 1973), and it is thought that a minimum 
Figure 8.  Proposed mechanism for the regulation 
of SC development by ILK. ILK plays distinct funda-
mental roles in the regulation of SC maturation. Early 
in development, ILK negatively regulates Rho/ROCK 
activity to trigger radial sorting. The phosphorylation 
of AKT on Ser-473 occurs in an ILK-dependent man-
ner. On an adult animal after a nerve CI, ILK is also 
required for the transition from a promyelinating to a 
myelinating SC during remyelination. AKT activity is 
likely to also play an important role in this final dif-
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antagonizes Rho/ROCK signaling (Riento et al., 2005) by bind­
ing and preventing ROCK I from interacting with its downstream 
targets (Riento et al., 2003). Our data, and the observation that 
short hairpin RNA–mediated knockdown of RhoE dramatically 
reduces process extension in primary rat SCs (our unpublished 
results), suggest that ILK regulation of RhoE is important in 
controlling SC process extension.
Finally, fasudil injections in mutant mice were sufficient 
to stimulate and reestablish radial sorting in mutant nerves. 
Together with our in vitro results, this supports the conclusion that 
inhibition of Rho/ROCK activity is essential to promote SC 
process extension and to initiate radial sorting. Other pathways 
than those regulated by ILK might also contribute to the nega­
tive regulation of Rho/ROCK signaling. Supporting this hypoth­
esis is the observation that the mean length of SC processes in 
control cultures treated with Y27632 or fasudil was increased in 
relation to nontreated controls, indicating that the ILK­mediated 
inhibition of Rho/ROCK signaling was not complete.
ILK regulates remyelination
Stimulation of radial sorting by ROCK inhibition in ILK mutant 
nerves did not result in an increase in the number of myelinated 
fibers. This suggests that ILK function might be required for my­
elination of axons and that the signaling mechanisms for radial 
sorting and myelination of axons are likely to be different. This 
hypothesis is further supported by experiments using myelinating 
dorsal root ganglia (DRG) explant cultures derived from E13.5 
mutant and control mice. In contrast to control DRG explant cul­
tures, ILK mutant cultures largely failed to myelinate even after 
10 d of continuous treatment with fasudil or Y27632 (Fig. S5).
The radial sorting phenotype of the ILK mutant prevented 
us from directly investigating the role of ILK in axonal myelina­
tion. Therefore, to address the role of ILK in myelin sheath for­
mation independently of radial sorting, we used an inducible gene 
ablation system (Leone et al., 2003) followed by nerve crush. We 
demonstrate that after SN CI in adult mice, ILK­deficient SCs es­
tablished 1:1 relations with axons, but a large proportion of 
axon–SC units failed to form myelin sheaths even 4 mo after CI. 
These findings indicate that at least during remyelination, ILK 
is required for the production of myelin sheaths.
ILK regulates AKT/PKB activation during 
PNS development
Phosphorylation of AKT/PKB can be regulated by the amount 
of neuregulin­1 type III present on the axon surface (Hu et al., 
2006; Nave and Salzer, 2006) and is thought to be critical for SC 
myelination (Campana et al., 1999; Maurel and Salzer, 2000; 
Ogata et al., 2004; Nave and Salzer, 2006). Loss of ILK reduced 
the levels of AKT/PKB phosphorylation on Ser­473 but not on 
Thr­308 during PNS development. In fact, the levels of AKT/
PKB phosphorylation on Thr­308 in mutant nerve lysates were 
even increased compared with controls. It is possible that in­
creased phosphorylation on Thr­308 partially compensates for 
reduced AKT/PKB phosphorylation on Ser­473. However, if 
this is true, such compensation is likely to be ILK independent. 
In cancer cells, ILK specifically regulates the phosphorylation 
of Ser­473 but not of Thr­308 (McDonald et al., 2008), raising 
bundles, (b) the formation of abnormal cytoplasmic protrusions 
projecting from the surface of ILK mutant SC–axon units,   
(c) the presence of layers of empty BL surrounding axon bun­
dles and SC–axon units in ILK mutant nerves, suggesting failed 
attempts of mutant SCs to engage axon bundles and individual 
axons, (d) the finding that ILK mutant SCs plated on laminin­2, 
a component of SC BL, produced shorter processes compared 
with controls, and (e) the observation that the dynamics of pro­
cess extension and retraction in mutant SCs was vastly increased 
as compared with controls.
The stability of the individual members of the IPP com­
plex  is  dependent  on  the  formation  of  the  complex  (Legate   
et al., 2006). In SCs, the loss of ILK resulted in reduced expres­
sion of other individual members of the IPP complex. Further­
more, the IPP complex can regulate the activity of Rho GTPases 
(Legate et al., 2006). We show that in ILK mutant nerves, the 
activities of Rac1, Cdc42, and Rho were increased compared 
with controls. Given that Rac1 activity is regulated by 1­integrin 
(Benninger et al., 2007; Nodari et al., 2007), the increase of ac­
tivity of Rac1 in the absence of ILK was somewhat surprising. 
However, in addition to 1­integrin, ILK also binds directly to 
3­integrin and indirectly to other receptors (Legate et al., 2006). 
This might explain why ILK regulation of Rac1 in particular, and 
Rho GTPases in general, does not mirror that of 1­integrin. In 
the PNS, the expression of RhoA, and of the two isoforms ROCK1 
and ROCK2, is developmentally regulated, peaking at the onset 
of myelination and dropping afterward (Melendez­Vasquez et al., 
2004). Other Rho proteins, i.e., RhoB and C, are also expressed 
in SCs (Terashima et al., 2001; Melendez­Vasquez et al., 2004), 
but their pattern of expression and specific functions are not 
known. Inhibition of ROCK by either Y27632 or fasudil re­
stored process extension to mutant SCs in culture, suggesting 
that in SCs, ILK controls process extension mainly through reg­
ulation of Rho/ROCK activity.
ILK is known to negatively regulate Rho/ROCK activity 
by different mechanisms, including integrin­dependent FAK ac­
tivation (Tahiliani et al., 1997; Wennerberg et al., 2000; Parsons, 
2003) and paxillin phosphorylation (Chen et al., 2005). Nega­
tive  regulation  of  Rho/ROCK  activation  by  FAK  might  be   
dependent on FAK/Src phosphorylation of p190Rho–GTPase­
activating protein (Schober et al., 2007) to promote Rho inacti­
vation. In this study, we show that in ILK mutant nerve lysates, 
the activation of FAK, measured by a phospho­specific antibody 
recognizing the FAK autophosphorylation residue tyrosine   
397, was significantly reduced as compared with controls. How­
ever, FAK appears to not regulate SC process extension, and 
SC­specific ablation of FAK mainly affects SC proliferation 
(Grove et al., 2007). Paxillin phosphorylation was also reduced 
in ILK mutant nerves. Paxillin is thought to participate in SC 
cytoskeletal reorganization (Chen et al., 2000), but its direct 
role in SC process extension has not been investigated. We also 
show in this study that RhoE expression is dramatically reduced 
in ILK mutant SCs. RhoE belongs to the Rnd subfamily of the 
Rho GTPases and, like the other subfamily members, binds but 
does not hydrolyze GTP (Riento et al., 2005). Therefore, it is 
not regulated by the classical GTP/GDP conformational switch 
of small Rho GTPases. RhoE exists in a GTP­bound state and JCB • VOLUME 185 • NUMBER 1 • 2009   158
For TUNEL staining, sections were fixed in 4% PFA for 10 min and blocked 
for 1 h with 10% goat serum, 1% Triton X-100, and 0.1% BSA in PBS. TUNEL 
assays were performed using indirect immunofluorescence to visualize nicked 
DNA according to the manufacturer’s instructions (Roche). For Oct6, ILK, 
MBP, and RhoE staining, frozen sections were fixed in 4% PFA for 5 min and 
submitted to antigen retrieval in 10 mM citrate buffer for 5 min at 98°C. Sec-
tions were blocked (1 mg/ml of BSA in PBS with 0.05% Triton X-100) for 1 h 
at RT and incubated with mouse antibodies against ILK (1:200; BD), RhoE 
(1:200; Abcam), rat against MBP (1:50; AbD Serotec), or rabbit antibody 
against Oct6 (1:200; Ghazvini et al., 2002) overnight at 4°C. After washing 
in PBS, sections were incubated for 1 h at RT with antibody against mouse or 
rabbit coupled to Cy3 (1:300; Jackson ImmunoResearch Laboratories) and 
rat coupled to Alexa Fluor 488 (1:300; Invitrogen). Sections were washed 
with  PBS,  incubated  for  5  min  with  DAPI,  and  mounted  in  Immu-Mount 
(Thermo Fisher Scientific).
Immunocytochemistry of SCs
Cultures were fixed in 4% PFA in microtubule protection (MP) buffer (65 mM 
Pipes, 25 mM Hepes, 10 mM EGTA, and 3 mM MgCl2, pH 6.9) for 10 min 
at RT. The cells were permeabilized with 0.2% Triton X-100 in MP buffer for 
5 min at RT and incubated with antibodies against ILK (1:200; BD), -tubulin 
(1:100; Sigma-Aldrich), RhoE (1:200; Abcam), or S100 (1:200; Dako) over-
night at 4°C. Cells were incubated with Cy3-conjugated anti–mouse (1:200; 
Jackson ImmunoResearch Laboratories), Alexa Fluor 488–conjugated anti–
rabbit (1:200; Jackson ImmunoResearch Laboratories), or Alexa Fluor 488–
conjugated phalloidin (1:100; Invitrogen) for 1 h at RT. Cells were washed in 
PBS, incubated with DAPI, and mounted in Immu-Mount.
Immunohistochemistry of DRG explant cultures
Cultures were fixed with 4% MP-PFA, postfixed in cold methanol (20°C), 
washed in PBS, and blocked for 1 h at RT in 5% BSA, 0.1% goat serum, 
and 0.2% Triton X-100 in PBS. DRG cultures were incubated in primary anti-
body against MBP (1:200) overnight at 4°C before being washed in PBS   
and incubated with a Cy3-conjugated antibody (1:300; SMI 94; Jackson 
ImmunoResearch Laboratories). After washing, the cultures were incubated 
with DAPI, washed again, and mounted. Chemicals were obtained from 
Sigma-Aldrich unless stated otherwise.
All images were acquired at RT using fluorescence microscopes with 
20×/0.4, 40×/0.6, or 100×/1.3 objectives (Vert Observer D1; Carl Zeiss, 
Inc.) or 20×/0.5, 40×/0.75, and 100×/1.3 objectives (Axioplan 2; Carl 
Zeiss, Inc.) equipped with charge-coupled device cameras (AxioCam HR or 
AxioCam MRm; Carl Zeiss, Inc.). Acquisition software was used (AxioVision 
4.6; Carl Zeiss, Inc.). Images were further processed (levels adjusted) using 
Photoshop software (CS2; Adobe).
Mouse SC cultures
Primary mouse SC cultures were established from P0–P2 SNs as described 
previously (Benninger et al., 2007).
Mouse DRG dissociated explants
DRGs were obtained from E13.5 control and mutant mouse embryos. In brief, 
DRGs were digested in enzymatic digestion solution (0.25% trypsin-EDTA; 
Invitrogen) and plated overnight on matrigel-coated coverslips (two DRGs per 
coverslip) in C medium (10% FCS and 50 ng/ml neural growth factor [Pepro-
Tech] in DME-Glutamax [Invitrogen]) supplemented with 1% penicillin/strepto-
mycin  (Invitrogen).  Then,  medium  was  changed  to  NB  medium  (2%  B27 
supplement [Invitrogen], 4 g/liter D-glucose [Sigma-Aldrich], 2 mM L-glutamine 
[Invitrogen], and 50 ng/ml neural growth factor in Neurobasal [Invitrogen]). 
Myelination was induced over 10 consecutive days with C medium supple-
mented with 50 mg/ml ascorbic acid (Sigma-Aldrich) in some experiments in 
the presence of PBS, 10 µM Y27632 (Sigma-Alrich), or 40 µM fasudil (EMD).
Teased fibers preparation
Nerves of P24 control and mutant mice were extracted from the animals and 
fixed with 4% PFA in PBS for 2 h at 4°C. Meanwhile, glass slides (Erie Scien-
tific) were coated with TESPA ((3-aminopropyl) triethoxysilane; Sigma-Aldrich) 
in the following procedure: 1 min in acetone and 1 min in 2% TESPA in ace-
tone followed by two acetone washes of 30 s each. After 2 h fixation, the 
nerves were washed with PBS, stripped of perineurium and epineurium, and 
cut into small pieces. Individual fibers were sorted in PBS using two acupunc-
ture needles (B-type; Seirin) on top of TESPA-coated glass slides. After teasing, 
the fibers were air dried and either stained immediately or stored at 20°C.
Immunostaining of teased fibers
Teased fibers were treated with prechilled acetone for 10 min, washed with 
PBS, and blocked in a buffer containing 5% fish gelatin (Sigma-Aldrich) 
the  interesting  possibility  that  Ser­473  phosphorylation  may 
regulate different downstream targets than phosphorylation on 
Thr­308 under certain conditions. After CI, the levels of AKT/
PKB phosphorylation on Ser­473 in tamoxifen­induced mutant 
nerve lysates were also reduced compared with controls. These 
results are consistent with the idea that ILK directly or indirectly 
regulates the phosphorylation of AKT/PKB on Ser­473. Based 
on this view, ILK can either function as a direct AKT/PKB Ser­
473 kinase or be involved in the cellular regulation of putative 
AKT/PKB Ser­473 kinases (Hill et al., 2002). Although in macro­
phages (Troussard et al., 2003), oligodendrocytes (Chun et al., 
2003), and primary skeletal muscle (Wang et al., 2008) the phos­
phorylation of AKT/PKB is dependent on ILK function, this re­
quirement appears to be cell type specific. Loss of ILK did not 
change AKT/PKB phosphorylation in chondrocytes (Grashoff   
et al., 2003), keratinocytes (Lorenz et al., 2007), or nestin­positive 
neural progenitors (Mills et al., 2006). In addition to differentia­
tion, the phosphorylation of AKT/PKB has been implicated in 
the control of SC proliferation and survival (Campana et al., 
1999; Monje et al., 2006). However, in ILK mutant nerves, pro­
liferation and survival was normal, indicating that the reduced 
levels of AKT/PKB phosphorylation were sufficient to promote 
SC proliferation and survival but not to support SC myelination.
In summary, we show that ILK and associated molecules 
of the IPP complex, functioning at the critical convergence of 
adhesion and growth factor signaling pathways, regulate radial 
sorting and remyelination of axons in the PNS. The multi­
dimensional nature of this regulation is likely to rely on the acti­
vation of a multitude of different downstream pathways besides 
those controlling Rho/ROCK and AKT/PKB activation. To un­
veil these pathways in detail and to study their impact on PNS 
myelination and remyelination remains an important task for 
the future. This knowledge will be essential for our basic under­
standing of nerve biology in health and disease.
Materials and methods
Generation of conditional knockout mice
The generation of conditional ILK mutant has been described previously 
(Grashoff et al., 2003). Mice homozygous for the ILK floxed allele (ILK
lox/lox) 
were crossed with mice heterozygous for the floxed allele and additionally 
expressing the Cre recombinase under the control of the Dhh promoter (Dhh-
cre
+ ILK
lox/w; Lindeboom et al., 2003) to obtain Dhh-cre
+ ILK
lox/lox mice (here-
after called ILK mutant mice) and Dhh-cre
+ ILK
lox/wt (hereafter called ILK control 
mice). Genotypes were determined by PCR on genomic DNA derived from 
tail biopsies. For remyelination experiments, the tamoxifen-inducible PLP-Cre-
ERT2 line was used (Leone et al., 2003). The breeding strategy to produce in-
ducible ILK mutant and control mice was the same as for Dhh-cre ILK mice.
EM
Mice were deeply anesthetized with 150 mg/kg pentobarbital i.p. (Nembu-
tal; Abbott laboratories) and perfused with 0.1 M phosphate buffer, pH 7.4, 
followed by buffer containing 3% glutaraldehyde and 4% PFA. Fixed tissues 
were postfixed in 2% osmium tetroxide, dehydrated through a graded acetone 
series as described previously (Benninger et al., 2006), and embedded in 
Spurr’s resin (Electron Microscopy Sciences). Semithin sections were stained 
with 1% Toluidine blue for analysis at the light microscope, and ultrathin sec-
tions were contrasted with 3% uranyl acetate and 1% lead citrate before ob-
servation in a transmission electron microscope (Morgagni 268; FEI).
Immunofluorescence and TUNEL staining
For Ki67 staining, frozen sections were submitted to antigen retrieval for   
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8 wk after the last tamoxifen injection, we performed SN CIs to induce re-
myelination. Mice were anesthetized by a single i.p. injection of 65 mg/
kg/bodyweight  Ketamine  (Ketaminol;  Vetenaria)  and  13  mg/kg/body-
weight Xylazine (Narcoxyl; Vetenaria). To prevent dehydration, a single 
i.p. injection of 1 ml Ringer’s lactate solution (B. Braun Medical) was ad-
ministered preoperatively. For analgesia, 0.1 mg/kg/bodyweight bupre-
norphinum (Temgesic; Essex Chemie) was injected just before the nerve 
crush and thereafter every 12 h for 2 d. SNs were analyzed distally from 
the crush site.
Morphometric analysis
The morphometric measurements in the fasudil experiment and the remye-
lination assays were performed in Toluidine blue–stained semithin sections 
(0.5 µm). For this purpose, a cross section per animal of the entire SN 
area  was  reconstructed  by  merging  several  high  magnification  photo-
graphs. The quantification of the 1:1 promyelinating cells, myelinated   
fibers, and axonal bundles was performed by counting all of the figures 
present in the entire SN cross section. The bundle area was quantified in 
pixels using Photoshop software (CS2) and converted to microns squared. 
The number of 1:1 and myelinated fibers was performed manually using 
the cell counter plugin from ImageJ software (click and count; National   
Institutes of Health). The quantification of SC process length in primary 
cultures was performed using ImageJ software in pixels and converted   
to microns.
Time-lapse microscopy
SCs were obtained from control and mutant SNs (Benninger et al., 2007) 
and plated on laminin substrates in media with or without ROCK inhibitors. 
SC cultures were imaged every 5 min over a period of 12 h in a live cell 
imaging station (37°C in 5% CO2; CellR; Olympus) using the CellR acquisi-
tion software (Olympus) and a 20×/0.45 air objective (Olympus). The re-
sulting  photographic  sequence  was  converted  into  a  film  (7  frames/s) 
using ImageJ (1.41). Quantification of process collapse events (process 
disappearing into the soma) was performed in films of three independent 
control and mutant cultures by tracking at least 10 cells per film.
Statistical analysis
The data show the mean ± SEM. Statistical significance was determined   
using a two-tailed Student’s t test. Significance was set at P < 0.05, P < 0.01, 
or P < 0.001. n represents the number of independent experiments.
Online supplemental material
Fig. S1 shows radial sorting defects present in dorsal and ventral roots. 
Fig. S2 demonstrates that the myelinating SCs in mutant nerves are not 
recombined. Fig. S3 compares the differentiation, total cell number, pro-
liferation, and apoptosis between control and ILK mutant SNs. Fig. S4 
shows that FAK and paxillin activation and RhoE expression are reduced 
in mutant nerves as compared with controls. Fig. S5 shows that the con-
tinuous pharmacological inhibition of ROCK does not rescue myelination 
deficits in dissociated mutant DRG explant cultures. Videos 1–4 show that 
in ILK mutant SCs, the frequency of process extension and retraction is 
increased  in  relation  to  controls.  Fasudil  treatment  abolishes  those  dif-
ferences.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200809008/DC1.
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and 0.1% Triton X-100 in PBS for 1 h at room RT. Primary antibodies against 
ILK (1:200; BD), neurofilament M (1:200; Sigma-Aldrich), and E-cadherin 
(1:200; Enzo Biochem, Inc.) were incubated overnight on blocking buffer 
inside a wet chamber. The following morning, the fibers were washed and 
incubated  with  Cy3-conjugated  anti–mouse  (1:200;  Jackson  Immuno-
Research Laboratories), Cy2-conjugated anti–rat (1:200; Jackson Immuno-
Research  Laboratories),  and  Cy5-conjugated  anti–rabbit  (1:50;  Jackson 
ImmunoResearch Laboratories) at RT in blocking buffer. Fibers were washed 
in PBS, incubated with DAPI for 5 min, and after subsequent washing, 
mounted with Immu-Mount. Images were acquired at RT using a confocal 
microscope (SP1; Leica) using a 63×/0.6-1.32 objective and confocal soft-
ware (LCS; Leica) in a sequential acquisition mode. Images were further 
processed (levels adjusted) using Photoshop software (CS2).
Quantitative real-time PCR
SNs were taken from P2 control and mutant mice, and total RNA was ex-
tracted using the RNeasy Mini kit (QIAGEN) according to their recommen-
dations. cDNA was produced using SuperScript III Reverse Transcriptase 
(Invitrogen). Quantitative real-time PCR analyses were performed on a Se-
quence Detection System (ABI 7000; Applied Biosystems) using the 2× 
SYBR Green PCR Master Mix (Applied Biosystems) according to the manu-
facturer’s recommendations. The amplification program was used for 5 min 
at 96°C, 40 steps of 30 s at 96°C, 30 s at 57°C, 30 s at 72°C, and 5 min 
at 72°C. The sequence of the primers used were as follows: glyceraldehyde 3-
phosphate  dehydrogenase  (forward,  5-CGTCCCGTAGACAAAATGGT-3; 
reverse, 5-TTGATGGCAACAATCTCCAC-3), ILK (forward, 5-TGGCTGG-
ACAACACAGAAAA-3; reverse, 5-TGATCAGCATTTCAACCACC-3), 
periaxin (forward, 5-AGGAATCTTTGTCCGTGAGC-3; reverse, 5-AGAA-
CACACGGGCACTCAG-3), PMP22 (forward, 5-GGGATCCTGTTCCTGCA-
CAT-3; reverse, 5-TGCCAGAGATCAGTCGTGTGT-3), P0/MPZ (forward, 
5-CCCTGGCCATTGTGGTTTAC-3; reverse, 5-CCATTCACTGGACCAG-
AAGGAG-3), and myelin-associated glycoprotein (forward, 5-CTGCCTTC-
AACCTGTCTGTG-3; reverse, 5-CGGGTTGGATTTTACCACAC-3).
Western blot
Mice at different developmental stages were sacrificed, and SNs were dis-
sected and separated from the epineurium and perineurium. They were   
homogenized with a chilled mortar and pestle in lysis buffer (0.1% SDS, 
10 mM Tris-HCl, 150 mM NaCl, 50 mM NaF, 1 mM NaVO4, 1 mM EDTA, 
0.5%  sodium-deoxycholate,  and  protease  inhibitor  cocktail  [Sigma-
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